Biomea Fusion (BMEA) Competitors $4.32 +0.07 (+1.65%) Closing price 04:00 PM EasternExtended Trading$4.35 +0.03 (+0.67%) As of 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BMEA vs. VECT, KURA, TECX, CRGX, HUMA, ANNX, PHVS, KROS, MREO, and RAPPShould you be buying Biomea Fusion stock or one of its competitors? The main competitors of Biomea Fusion include VectivBio (VECT), Kura Oncology (KURA), Tectonic Therapeutic (TECX), CARGO Therapeutics (CRGX), Humacyte (HUMA), Annexon (ANNX), Pharvaris (PHVS), Keros Therapeutics (KROS), Mereo BioPharma Group (MREO), and Rapport Therapeutics (RAPP). These companies are all part of the "pharmaceutical products" industry. Biomea Fusion vs. VectivBio Kura Oncology Tectonic Therapeutic CARGO Therapeutics Humacyte Annexon Pharvaris Keros Therapeutics Mereo BioPharma Group Rapport Therapeutics VectivBio (NASDAQ:VECT) and Biomea Fusion (NASDAQ:BMEA) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, community ranking, dividends, profitability, valuation, media sentiment and analyst recommendations. Is VECT or BMEA more profitable? VectivBio's return on equity of 0.00% beat Biomea Fusion's return on equity.Company Net Margins Return on Equity Return on Assets VectivBioN/A N/A N/A Biomea Fusion N/A -118.90%-93.66% Do institutionals & insiders have more ownership in VECT or BMEA? 96.7% of Biomea Fusion shares are owned by institutional investors. 9.7% of VectivBio shares are owned by insiders. Comparatively, 27.6% of Biomea Fusion shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community believe in VECT or BMEA? Biomea Fusion received 48 more outperform votes than VectivBio when rated by MarketBeat users. Likewise, 69.05% of users gave Biomea Fusion an outperform vote while only 43.48% of users gave VectivBio an outperform vote. CompanyUnderperformOutperformVectivBioOutperform Votes1043.48% Underperform Votes1356.52% Biomea FusionOutperform Votes5869.05% Underperform Votes2630.95% Which has higher earnings & valuation, VECT or BMEA? VectivBio has higher revenue and earnings than Biomea Fusion. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVectivBio$27.34MN/A-$93.74MN/AN/ABiomea FusionN/AN/A-$117.25M-$4.01-1.08 Does the media prefer VECT or BMEA? In the previous week, VectivBio had 1 more articles in the media than Biomea Fusion. MarketBeat recorded 1 mentions for VectivBio and 0 mentions for Biomea Fusion. Biomea Fusion's average media sentiment score of 0.35 beat VectivBio's score of 0.00 indicating that Biomea Fusion is being referred to more favorably in the news media. Company Overall Sentiment VectivBio Neutral Biomea Fusion Neutral Do analysts recommend VECT or BMEA? Biomea Fusion has a consensus target price of $39.36, indicating a potential upside of 811.20%. Given Biomea Fusion's stronger consensus rating and higher probable upside, analysts plainly believe Biomea Fusion is more favorable than VectivBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score VectivBio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Biomea Fusion 0 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 3.00 SummaryBiomea Fusion beats VectivBio on 9 of the 14 factors compared between the two stocks. Get Biomea Fusion News Delivered to You Automatically Sign up to receive the latest news and ratings for BMEA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BMEA vs. The Competition Export to ExcelMetricBiomea FusionPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$156.56M$6.55B$5.40B$9.24BDividend YieldN/A2.96%5.37%3.99%P/E Ratio-1.089.9389.1417.52Price / SalesN/A335.641,226.4979.25Price / CashN/A64.1243.6036.96Price / Book0.915.105.014.72Net Income-$117.25M$154.90M$117.89M$224.61M7 Day Performance6.40%1.58%1.91%1.54%1 Month Performance2.13%1.75%3.89%5.12%1 Year Performance-70.39%4.64%26.59%21.25% Biomea Fusion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BMEABiomea Fusion2.7778 of 5 stars$4.32+1.6%$39.36+811.2%-69.5%$156.56MN/A-1.0850VECTVectivBioN/A$16.85flatN/AN/A$573.24M$27.34M0.0030News CoverageKURAKura Oncology4.452 of 5 stars$7.24-1.1%$27.38+278.1%-49.7%$563.01MN/A-3.07130Analyst RevisionTECXTectonic Therapeutic3.012 of 5 stars$37.83-5.8%$72.25+91.0%N/A$558.11MN/A-6.42120Positive NewsCRGXCARGO Therapeutics1.7011 of 5 stars$12.04-10.8%$31.80+164.1%-38.1%$554.18MN/A-2.83116HUMAHumacyte2.8548 of 5 stars$4.39-4.8%$13.71+212.4%+70.8%$552.52M$1.57M-3.28150Analyst ForecastANNXAnnexon2.4063 of 5 stars$4.94+2.3%$15.80+219.8%-3.9%$526.57MN/A-4.7060Analyst RevisionNews CoveragePositive NewsPHVSPharvaris2.2788 of 5 stars$16.41-7.8%$39.25+139.2%-29.9%$522.49MN/A-5.8630Analyst RevisionHigh Trading VolumeKROSKeros Therapeutics2.7949 of 5 stars$12.82-12.0%$75.00+485.0%-78.5%$519.30M$651,000.00-2.46100Analyst DowngradeAnalyst RevisionNews CoverageHigh Trading VolumeMREOMereo BioPharma Group1.9692 of 5 stars$3.34-5.9%$7.83+134.5%-5.2%$518.19M$1M0.0040Gap DownRAPPRapport Therapeutics1.7263 of 5 stars$13.97-5.7%$35.00+150.5%N/A$510.97MN/A0.00N/A Related Companies and Tools Related Companies VECT Alternatives KURA Alternatives TECX Alternatives CRGX Alternatives HUMA Alternatives ANNX Alternatives PHVS Alternatives KROS Alternatives MREO Alternatives RAPP Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BMEA) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behi...Porter & Company | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomea Fusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biomea Fusion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BMEA Stock Alerts